Your browser doesn't support javascript.
loading
Chemokine profile in women with moderate to severe anxiety and depression during pregnancy.
Camacho-Arroyo, Ignacio; Flores-Ramos, Mónica; Mancilla-Herrera, Ismael; Cruz, Fausto Moisés Coronel; Hernández-Ruiz, Joselin; Diaz, Gabriela Pellón; Labonne, Blanca Farfán; Del Pilar Meza-Rodríguez, María; Gelman, Philippe Leff.
Afiliação
  • Camacho-Arroyo I; Unidad de Investigación en Reproducción Humana, Instituto Nacional de Perinatología-Facultad de Química, Universidad Nacional Autónoma de México, (CD MX) 04510, Mexico City, Mexico.
  • Flores-Ramos M; Instituto Nacional de Psiquiatría, CD MX 14370, Mexico City, Mexico.
  • Mancilla-Herrera I; Consejo Nacional de Ciencia y Tecnología/CONACyT, CD MX 03940, Mexico City, Mexico.
  • Cruz FMC; Departamento de Neurociencias, Instituto Nacional de Perinatología, Av. Montes Urales # 800. Col. Lomas de Virreyes, CD MX 11000, Mexico City, Mexico.
  • Hernández-Ruiz J; Clinical Pharmacology Unit, Hospital General de México Dr. Eduardo Liceaga, CD MX 06720, Mexico City, Mexico.
  • Diaz GP; Clinical Pharmacology Unit, Hospital General de México Dr. Eduardo Liceaga, CD MX 06720, Mexico City, Mexico.
  • Labonne BF; División of Nephology and Hypertension, University of Utah, Salt Lake City, UT, 84112, USA.
  • Del Pilar Meza-Rodríguez M; Departamento de Neurociencias, Instituto Nacional de Perinatología, Av. Montes Urales # 800. Col. Lomas de Virreyes, CD MX 11000, Mexico City, Mexico.
  • Gelman PL; Departamento de Neurociencias, Instituto Nacional de Perinatología, Av. Montes Urales # 800. Col. Lomas de Virreyes, CD MX 11000, Mexico City, Mexico.
BMC Pregnancy Childbirth ; 21(1): 807, 2021 Dec 04.
Article em En | MEDLINE | ID: mdl-34863117
ABSTRACT

BACKGROUND:

Cytokine levels have been extensively described in pregnant subjects under normal and pathological conditions, including mood-related disorders. Concerning chemokines, very few studies have reported their association with psychiatric disorders during pregnancy. Therefore, we explored the chemokine profile in women exhibiting anxiety and depression during late pregnancy in the present study.

METHODS:

One hundred twenty-six pregnant women in the 3rd trimester of pregnancy, displaying moderate to severe anxiety (ANX) alone and women exhibiting moderate to severe anxiety with comorbid depression (ANX + DEP), and 40 control pregnant women without affective disorders (CTRL) were evaluated through the Hamilton Anxiety Rating Scale (HARS) and the Hamilton Depression Rating Scale (HDRS). Serum chemokine levels of MCP-1 (CCL2), RANTES (CCL5), IP-10 (CXCL10), Eotaxin (CCL11), TARC (CCL17), MIP-1α (CCL3), MIP-1ß (CCL4), MIG (CXCL9), MIP-3α (CCL20), ENA-78 (CXCL5), GROα (CXCL1), I-TAC (CXCL11) and IL-8 (CXCL8)] were measured by immunoassay. Clinical, biochemical, and sociodemographic parameters were correlated with HARS and HDRS score values.

RESULTS:

Serum levels of most chemokines were significantly higher in the ANX and in the ANX + DEP groups, when compared to the CTRL group. Positive correlations were observed between MIP-1α/CCL3, MIP-1ß/CCL4, MCP-1/CCL2, MIP-3α/CCL20, RANTES/CCL5, Eotaxin/CCL11, and I-TAC/CXCL11 with high scores for anxiety (HARS) (p < 0.05) and for depression (HDRS) (p < 0.004). After controlling clinical measures for age + gwk + BMI, chemokines such as IL-8/CXCL8, MCP-1/CCL2 and MIP-1ß/CCL4 were found associated with high scores for anxiety (p < 0.05) in the ANX group. TARC/CCL17 and Eotaxin/CCL11 showed significant associations with high scores for depression (p < 0.04) whereas, MCP-1/CCL2 and MIP-1α/CCL3 were significantly associated with high scores for anxiety (p < 0.05) in the ANX + DEP group. Using a multivariate linear model, high serum levels of MIP-1ß/CCL4 and Eotaxin/CCL11 remained associated with depression (p < 0.01), while, IL-8/CXCL8, MIP-1ß/CCL4, MCP-1/CCL2, and MIP-1α/CCL3 were associated with anxiety (p < 0.05) in the symptomatic groups.

CONCLUSIONS:

Our data show that serum levels of distinct chemokines are increased in women exhibiting high levels of affective symptoms during late pregnancy. Our results suggest that increased levels of anxiety, depressive symptoms, and mood-related disorders may promote changes in specific functional chemokines associated with a chronic inflammatory process. If not controlled, it may lead to adverse obstetric and negative neonate outcomes, child development and neuropsychiatric alterations in the postnatal life. HIGHLIGHTS Chemokine levels increase in affective disorders during pregnancy.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ansiedade / Complicações na Gravidez / Quimiocinas / Transtornos do Humor / Depressão Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Pregnancy País/Região como assunto: Mexico Idioma: En Revista: BMC Pregnancy Childbirth Assunto da revista: OBSTETRICIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: México

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ansiedade / Complicações na Gravidez / Quimiocinas / Transtornos do Humor / Depressão Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Pregnancy País/Região como assunto: Mexico Idioma: En Revista: BMC Pregnancy Childbirth Assunto da revista: OBSTETRICIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: México